RAMESH KUMAR
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
AJAY BANSAL, HENRY S BIENEN, HENRY S. BIENEN, HENRY S. BIENEN, PH.D., HENRY B. BINEN, WERNER CAUTREELS, TRAFFORD CLARKE, IAN DUKES, STEVEN FRUCHTMAN, STEVEN M. FRUCHTMAN, JEROME E. GROOPMAN, MARK GUERIN, MARK P. GUERIN, MICHAEL HOFFMAN, MICHAEL B. HOFFMAN, RAMESH KUMAR, PH.D, RAMESH KUMAR, PH.D., SHEKHAR KUNDUR, MANOJ MANIAR, JAMES MARINO, JAMES J. MARINO, THOMAS MCKEARN, VIREN MEHTA, ABRAHAM N. OLER, PANKAJ PATEL, DAVID PAUZA, K RAVINDRA, K. RAVINDRA, E. PREMKUMAR REDDY, PREMKUMAR REDDY, E. PREMKUMAR REDDY, PH.D, E. PREMKUMAR REDDY, PH.D., ROBERT REDFIELD, NIKOLAY SAVCHUK, M. THERESA SHOEMAKER, JACK E. STOVER, ANNE M. VANLENT, ALAN R. WILLIAMSON, RICHARD C. WOODMAN
DIRECTOR
KIRK ANDRIANO, RASAPPA ARUMUGHAM, JOSHUA BALTZELL, KELLY BECK, BRIAN CALLAHAN, KRISTEN CASTILLO, PRABHAVATHI FERNANDES, PATRICK FORTUNE, DAVID GILL, PETER GREENLEAF, ADAM GRIDLEY, JOHN JOHNSON, JOHN J. JOHNSON, DANIEL JORGENSEN, UDAY B KOMPELLA, GARHENG KONG, GARHENG KONG, M.D., PH.D, GARHENG KONG, M.D., PH.D., MICHAEL LEWIS, JONATHAN LIEBER, KEVIN MCARDLE, SHANKAR MUSUNURI, PATRICK O-DONNELL, MANISH POTTI, PHILIP PRESS, KEVIN RAKIN, DOMINIC REDFERN, HARRY REIN, SANJAY SUBRAMANIAN, VIJAY TAMMARA, LAURENCE J.B. TARRANT, SUHA TASPOLATOGLU, JUNGE ZHANG
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-04-22
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity, Debt
2020-04-22
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2018-04-05

